QUANTUM - DRIVEN THERANOSTICS PLATFORM
CENTERS SUPPORT
CENTERS SUPPORT
The ICPO Foundation offers a structured accreditation pathway that recognizes centers‘ current achievements and also engages in providing a clear roadmap for future development, based on assessment and interaction with the individual centers in their local context. Whether a center is newly established or already a global leader, this framework ensures adequate support at every stage, enhancing growth and strengthening expertise in Theranostics.
Supporting Growth Path from Clinical to Comprehensive Center by:
- Optimizing workflow and process designs
- Analyzing multidisciplinary tumor boards effectiveness
- Increasing patient referrals and external visibility
Enhancing Local Networks and Visibility for ICPO Theranostics Centers by:
- Organizing a Theranostics Day at the Theranostics Center
- Engaging with multidisciplinary colleagues & referring physicians
- Increasing awareness of local patient associations
Empowering Theranostics Healthcare Professionals by:
- Offering certified e-Education through Academy
- Providing free access to via industry sponsored stipends
- Accessing Observational Theranostics Trainings
“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”
Prof. Mike Sathekge,
CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa
“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”
Prof. Mike Sathekge,
CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa
“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”
Prof. Mike Sathekge,
CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa